Results for Oncoprotein BCR-ABL

Rss Feed: Click here

Xanthohumol induces caspase-dependent degradation of oncoprotein BCR-ABL in K562 cells.

Article Published Date : Sep 15, 2019

Study Type : In Vitro Study

Additional Links

Substances : Xanthohumol : CK(55) : AC(33)

Diseases : Leukemia: Chronic myelogenous leukemia (CML) : CK(66) : AC(48)

Pharmacological Actions : Antiproliferative : CK(6801) : AC(5032), Apoptotic : CK(6986) : AC(5304), Cell cycle arrest : CK(1678) : AC(1348)

Additional Keywords : Oncoprotein BCR-ABL

Click here to view the entire abstract

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.